The ai enabled imaging solutions market has seen considerable growth due to a variety of factors.
• In recent times, the market size for AI-enabled imaging solutions has seen a sharp surge. This market is projected to expand from $3.22 billion in 2024 to an estimated $4.14 billion in 2025, representing a compound annual growth rate (CAGR) of 28.3%.
This impressive growth rate during the historical period is largely due to factors such as the surging demand for accurate diagnostics and treatment plans, increased expenditure on healthcare, a rise in the frequency of chronic diseases, the growing use of AI-enabled imaging solutions in the field of oncology, increased governmental initiatives, as well as an increase in funding for AI research and development of healthcare infrastructure.
The ai enabled imaging solutions market is expected to maintain its strong growth trajectory in upcoming years.
• There is anticipatory sky-rocketing growth in the market size of AI-enabled imaging solutions in the forthcoming years. The expansion predicted will catapult the market to a whopping $11.1 billion in 2029, growing at a compound annual growth rate (CAGR) of 28.0%.
Driving factors during the forecast period include the development in telemedicine, an increasing spotlight on preemptive healthcare, growth in partnerships and collaborations between healthcare providers and AI solution vendors, and the evolution of regulatory mechanisms and ethical guidelines. Significant trends for the forecast duration encompass improvements in AI algorithms, amalgamation of several imaging modes, the shift towards cloud-centric AI solutions, a heightened focus on explainable AI (XAI), and the initiation of edge computing in AI-enabled imaging gadgets.
The AI-enabled imaging solutions market is forecasted to grow owing to the increasing prevalence of breast cancer. The term breast cancer refers to the aberrant proliferation of cells in the breast tissue that can turn into a malignant growth with the capacity to metastasize to other body parts. The upswing in breast cancer incidence can be traced back to alterations in lifestyle including dietary habits, lack of physical exercise, and hormonal influences. These escalate the need for advanced healthcare solutions. AI-supported imaging systems lend a hand in the early spotting of breast cancer via automated mammogram analysis. They enhance the precision of diagnoses, allowing for swift action and ultimately improving patient prognoses. As an example, the American Cancer Society, a non-profit cancer advocacy body based in the US, reported in January 2023 an increase in breast cancer patients in the country from 284,200 in 2021 to 300,590 in 2023, indicating a 5.76% rise. Hence, the escalating number of breast cancer cases is fueling the expansion of the AI-enabled imaging solutions market.
The AI-enabled imaging solutions market covered in this report is segmented –
1) By Offering: Software Tools Or Platform, Services
2) By Image Acquisition Technology: X-ray, Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging, Molecular Imaging
3) By Technology: Machine Learning, Natural Language Processing, Context Aware Computing, Computer Vision
4) By End User: Hospitals, Clinics, Research Laboratories And Diagnostic Centers, Cybersecurity
Subsegments:
1) By Software Tools Or Platform: AI-Powered Image Analysis Software, AI-based Image Recognition Tools, AI Imaging Platforms For Healthcare, AI For Image Enhancement And Editing
2) By Services: AI Image Consulting Services, AI Imaging Implementation Services, AI-based Imaging Data Analysis Services, Cloud-Based AI Imaging Services
Leading corporations in the AI-enabled imaging solutions market are aiming to strengthen their market position by developing high-tech solutions like AI-integrated MRI (Magnetic Resonance Imaging) systems. Such systems are MRI scanners that have been outfitted with artificial intelligence, boosting their image capture, processing, analysis, and interpretation abilities. As an example, in December 2023, US medical technology firm, GE Healthcare Technologies Inc. unveiled SIGNA Champion, an AI-intensive MRI system encompassing advanced AI and deep learning features like AIR Recon DL and Sonic DL to support accurate and quicker scanning. Furthermore, the system is designed with sustainability and operational advantages in mind, with a reduced physical presence and improved energy efficiency. In parallel with SIGNA Champion, GE Healthcare also launched SIGNA PET/MR AIR that leverages artificial intelligence to enhance the diagnosis and management of diseases like prostate cancer and Alzheimer's.
Major companies operating in the AI-enabled imaging solutions market report are:
• Medtronic PLC
• NVIDIA Corporation
• Siemens Healthineers
• Fujifilm Holdings Corporation
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Zebra Medical Vision Ltd.
• Hologic Inc.
• Agfa-Gevaert Group
• Samsung Medison Co. Ltd.
• Konica Minolta Healthcare Americas Inc.
• Intelerad Medical Systems
• Hitachi Medical Systems
• Merative L.P.
• Canon Medical Systems Corporation
• Aidoc Medical Ltd.
• Butterfly Network Inc.
• HeartFlow Inc.
• Arterys Inc.
• Caption Health Inc.
• EchoNous Inc.
• Vuno Inc.
• Mirada Medical Limited
• Resoundant Inc.
• Lunit Inc.
North America was the largest region in the AI-enabled imaging solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the AI-enabled imaging solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.